TRIB
Trinity Biotech plc
Company Overview
| Mkt Cap | $18.63M | Price | $1.00 |
| Volume | 39.72K | Change | +0.00% |
| P/E Ratio | -0.8 | Open | $1.00 |
| Revenue | $56.8M | Prev Close | $1.00 |
| Net Income | $-24.0M | 52W Range | $0.48 - $3.44 |
| Div Yield | N/A | Target | $15.00 |
| Overall | 23 | Value | -- |
| Quality | 36 | Technical | 10 |
No chart data available
Stock Overview
Updated DailyTrinity Biotech plc (TRIB) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $1.00 with a market capitalization of $18.63 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TRIB with a volume of 40K shares. The stock opened down 0.50% from yesterday's close of $1.00. Current analyst estimates project earnings of $-7.08 per share for this year, with next year targeting $-4.36.
TRIB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OSUR, BIO, ALR, QDEL, CEMI.
Key investment considerations for TRIB include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 1400.0%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 05:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRIB | $1.00 | 0% | 39.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |